Brief: Case Study CyPath® Lung Detects Stage 1A Lung Cancer In High-Risk Patient With Inconclusive Imaging And Low-Risk Serum Test Results
29/07/2025 14:34
July 29 (Reuters) - bioAffinity Technologies Inc BIAF.O: CASE STUDY: CYPATH® LUNG DETECTS STAGE 1A LUNG CANCER IN HIGH-RISK PATIENT WITH INCONCLUSIVE IMAGING AND LOW-RISK SERUM TEST RESULTS Source text: ID:nBw2SKNGha Further company coverage: BIAF.O ((Reuters.Briefs@thomsonreuters.com;))